In-vitro and in-silico determinations of HMG-CoA reductase inhibition potential of caffeic acid for therapeutics of hypercholesterolemia
Abstract
The recent study was aimed to investigate in-vitro and in-silico determinations of the 3-hydroxy-3-methyl-glutarylcoenzyme A reductase [HMG-CoA reductase (HMGCR)] inhibition potential of the caffeic acid.The in-vitro assay shown the IC 50 values of caffeic acid and pravastatin by 10.162 µM and 40.6 nM which performed up to 83.29% and 85.83% inhibition of HMGCR, respectively.Consequently, the kinetics of inhibition of HMGCR showed significant values of K m and V max of the caffeic acid (0.360198 ± 0.04251; 11.8% and 91.0863 ± 1.65; 1.811%) and pravastatin (10.325 ± 0.9372) [9.077%; 94.2661 ± 2.458 (2.607%)].Consequently, the molecular docking revealed significant binding energy, bond length, and H-boding of caffeic acid with target enzyme of HMGCR.Accordingly, the interactions of protein-ligand complexes under cytosolic conditions were validated through root mean score fluctuation of molecular dynamics.Subsequently, the gastrointestinal absorption authenticated by the BOILED egg prediction is further validated by Absorption, Distribution, Metabolism, Excretion, And Toxicity (ADMET) assays and iLogP value.The drug likeness values of caffeic acid and pravastatin were found suitable as per the five rules of the Lipinski.Supportively, the toxicity profiles of the caffeic acid and pravastatin was made by the ProTox-II web server.Hence, it can be concluded that caffeic acid has the capabilities to inhibit HMGCR which provides the hypocholesterolemic potential.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.